A1339 - 2′-FL, 3-FL, LNT, 3′-SL, and 6′-SL from GM Escherichia coli BL21 for use as nutritive substances in infant formula products

This application seeks to permit the voluntary use of 2′-FL, 3-FL, LNT, 3′-SL, and 6′-SL, alone or in combination, as nutritive substances in infant formula products. The nutritive substance ingredients are derived from various genetically modified Escherichia coli BL21 strains.

Consultation and assessment

Call for submissions

• A1339 Call for submissions (693 KB)
• A1339 Supporting document (1 MB)
• A1339 Application (2.4 MB)

The call for submissions closed on 6 March 2026. Submissions from the public consultation have been published on the A1339 Consultation Hub page.

Administrative Assessment

• A1339 Administrative Assessment Report (191 KB)

• A1339 Executive Summary (196 KB)